Questcor Pharmaceuticals, Inc. (QCOR)

[ronpopeil]

Questcor price target raised to $53 from $45 at Oppenheimer
Oppenheimer raised its price target for Questcor after its survey indicated that company's opportunity in multiple sclerosis for Acthar may be larger than previously expected. Opco said it would be a buyer of the stock ahead of the next Acthar script update which it believes could occur on December 12. :theflyonthewall